Medical weight loss should be supervised, personalized, and focused on long-term metabolic health, not just the number on the scale
Early clinical observations indicated substantial reductions in liver fat content, prompting interest in the compound as a research tool for studying metabolic-associated steatotic liver disease (MASLD)
Psychological barriers : Some patients experience frustration, get discouraged, or have anxiety related to treatment expectations and results, leading to nonadherence
These early appetite shifts can make it easier to reduce portions and avoid frequent snacking, which may lead to gradual weight loss even at the starter dose
That may sound strict, but it is practical: poor gut clearance impairs estrogen metabolism and can worsen symptoms even when hormones are replaced
The science is there, the ingredients are efficacious, and the results are proven